Dravet syndrome, an early onset epileptic encephalopathy, is most often caused by de novo mutation of the neuronal voltage-gated sodium channel gene SCN1A. Mouse models with deletion of Scn1a recapitulate Dravet syndrome phenotypes, including spontaneous generalized tonic-clonic seizures, susceptibility to seizures induced by elevated body temperature, and elevated risk of sudden unexpected death in epilepsy. Importantly, the epilepsy phenotype of Dravet mouse models is highly strain-dependent, suggesting a strong influence of genetic modifiers. We previously identified Cacna1g, encoding the Cav3.1 subunit of the T-type calcium channel family, as an epilepsy modifier in the Scn2a Q54 transgenic epilepsy mouse model. In this study, we asked whether transgenic alteration of Cacna1g expression modifies severity of the Scn1a +/À Dravet phenotype. Scn1a +/À mice with decreased Cacna1g expression showed partial amelioration of disease phenotypes with improved survival and reduced spontaneous seizure frequency. However, reduced Cacna1g expression did not alter susceptibility to hyperthermia-induced seizures. Transgenic elevation of Cacna1g expression had no effect on the Scn1a +/À epilepsy phenotype. These results provide support for Cacna1g as a genetic modifier in a mouse model of Dravet syndrome and suggest that Cav3.1 may be a potential molecular target for therapeutic intervention in patients.
Dravet syndrome is an epileptic encephalopathy most often caused by de novo heterozygous loss of function mutation in the neuronal voltage-gated sodium channel gene SCN1A. 1 In addition to pleiomorphic seizures that are often refractory to treatment, Dravet syndrome includes cooccurring neurodevelopmental delay and elevated risk of sudden unexpected death in epilepsy (SUDEP). 1 A number of mouse models with heterozygous deletion of Scn1a have been developed to better understand the underlying mechanisms of Dravet syndrome and to develop novel treatment strategies.
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Scn1a
+/À mice experience spontaneous generalized tonic-clonic seizures (GTCSs), seizures provoked by elevated body temperature, and reduced lifespan, similar to individuals with Dravet syndrome. [2] [3] [4] Interestingly, the epilepsy phenotype of Scn1a +/À mice is highly strain-dependent. 2, 4 Scn1a +/À mice maintained on a 129 strain (either 129S6/SvEvTac or 129/SvJ) are unaffected, with no evidence of spontaneous seizures and a normal lifespan. 2, 4 In contrast, when crossed to C57BL6/J (B6), [B6x129] F1.Scn1a +/À mice display hallmark Dravet phenotypes, including spontaneous seizures, reduced lifespan, and susceptibility to hyperthermia-induced seizures. 2, 4 Whole genome mapping identified several genetic modifier loci (Dsm1-5) that influence survival of Scn1a +/À mice. 4 Fine mapping of the Dsm1 locus on mouse chromosome 5 resulted in the identification of Gabra2 as a modifier of the Scn1a +/À Dravet mouse model. 5 Another locus was mapped to chromosome 11, although the 1.5-LOD support interval was proximal to Cacna1g. 5 These observations support the hypothesis that genetic modifiers influence expressivity of epilepsy in Dravet syndrome. We previously identified Cacna1g, encoding the Cav3.1 subunit of the T-type calcium channel family, as a genetic modifier in the Scn2a Q54 transgenic epilepsy mouse model. 6, 7 Transgenic alteration of Cacna1g expression influenced the Scn2a Q54 phenotype. 7 Other epilepsy modifier genes, including Hlf and Kcnq2, influence phenotypes in both Scn2a Q54 and Scn1a epilepsy mouse models. 8, 9 In the current study, we evaluated the effect of transgenic alteration of Cacna1g expression on the Scn1a +/À epilepsy phenotype. Scn1a
+/À mice with decreased Cacna1g expression exhibited improved survival and decreased spontaneous seizure frequency. These results provide support for Cacna1g as a genetic modifier in a mouse model of Dravet syndrome and suggest that Cav3.1 may be a potential molecular target for therapeutic intervention in patients.
Methods
Mice
Scn1a tm1Kea (1A +/À ) mice (Mutant Mouse Regional Resource Center [MMRRC] stock #37107-JAX) congenic on 129S6/SvEvTac (129) were previously described and are maintained by continued backcrossing to 129S6/SvEvTac (Taconic). 4 The global heterozygous null Cacna1g +/À (B6.1G +/À ) line was previously described and is maintained by backcrossing of heterozygous B6.1G +/À offspring to C57BL/6J (Jackson Laboratory, 000664). 10 The previously described B6.Cacna1gHIGH (B6.1GH) BAC transgenic line Tg(RP23-65I14)1Kea (MMRRC stock #42089-JAX), with elevated Cacna1g expression, is maintained by backcrossing of hemizygous mice to C57BL/6J. 7 B6.1G +/À and B6.1GH females were crossed with 129.1A +/À males to generate double transgenic (1A +/À ;1GH or 1A +/À ;1G +/À ) mice and single mutant littermate controls. Mice were genotyped by polymerase chain reaction (PCR) of DNA isolated from postnatal day 14 (P14) tail biopsies as described. 7, 11 Mice were group-housed with access to food and water ad libitum and maintained on a 14-h light/10-h dark schedule. All studies were approved by the Northwestern University Animal Care and Use Committee in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Principles outlined in the ARRIVE guideline and Basel declaration were considered when planning the experiments. There were no significant differences between sexes on any measurements, so groups were collapsed across sex.
Survival
At P21, mice were weaned into cages containing 4-5 mice of the same sex and survival was monitored to 8 weeks of age. All mice were monitored daily for general health, and any mouse that was visibly unhealthy (e.g., underweight, dehydrated, poorly groomed, or immobile) was euthanized and excluded from the study. Survival cohorts were analyzed using Mantel-Cox log-rank test, and p < 0.05 was considered statistically significant.
Hyperthermia-induced seizure threshold
Susceptibility to hyperthermia-induced seizures was tested as previously described. 12 Body temperature was recorded when a GTCS occurred. Hyperthermia-induced seizure threshold was analyzed using Mantel-Cox log-rank test, and p < 0.05 was considered statistically significant.
Continuous video monitoring of spontaneous seizure activity
Mice were phenotyped as previously described. 5, 12 Prior extensive video-electroencephalographic (video-EEG) monitoring of 1A +/À mice demonstrated a perfect correlation between behavioral and EEG seizures (j = 1.0), validating visual assessment of GTCSs. 5 Behavioral seizures were assessed offline by an observer blinded to genotype, counting the number of GTCSs. A 48-h window of time from 24:00 on P22 to 24:00 on P24 was reviewed for each subject.
A separate cohort of mice were subjected to a single, brief hyperthermia-induced GTCS event at P18 and then were video monitored for spontaneous GTCSs until P22. 12 A 60-h window of time from 12:00 on P19 to 24:00 on P21 was reviewed. Seizure frequencies were compared between genotypes using Mann-Whitney rank-sum test, with p < 0.05 being considered statistically significant.
Video-EEG
Video-EEG experiments were performed as previously described. 5, 8, 11 Briefly, mice were implanted with prefabricated head mounts (Pinnacle Technology) under isoflurane anesthesia. After 48-h recovery, mice underwent continuous video-EEG monitoring until at least P26. EEG and synchronized video recordings were reviewed manually to identify electrographic seizures and behavioral correlates. All electrographic seizures correlated with behavioral tonic-clonic convulsions with loss of posture. A total of five (three males; two females) 1A +/À ;1G +/À mice were evaluated by video-EEG (857 total hours). There was no evidence of electrographic seizures in two 1G +/À mice evaluated by video-EEG (381 total hours). Previous extensive video-EEG recording of Cacna1g BAC transgenic mice revealed spike-wave discharges, but no GTCSs. 13 
Transcript analysis
Cacna1g mRNA expression levels were analyzed similarly as described previously. 7 Brains were collected from P19 mice 24 h after a single hyperthermia-induced GTCS event or sham treatment (10-min hold at 37°C). Total RNA was extracted from whole brains using Trizol (Life Technologies), and first-strand cDNA was generated using Super-Script III (Life Technologies). Quantitative droplet digital PCR (ddPCR) was performed using ddPCR Supermix for Probes (No dUTP) (Bio-Rad) and TaqMan Gene Expression Assays (Life Technologies) for Cacna1g (FAM_Mm00486571_m1) and TATA binding protein (Tbp; VIC_Mm00446971_m1). Reactions were partitioned into droplets, amplified, and analyzed according to the manufacturer's recommendations (Bio-Rad). Relative transcript levels were expressed as a ratio of Cacna1g/Tbp concentration and compared between groups by Student t test, with p < 0.05 being considered statistically significant.
RNA-seq
Sequence-based transcriptome analysis of 129S6/SvEvTac and [C57BL/6 9 129S6/SvEvTac]F1 hippocampus was previously reported. 5 Briefly, sequence reads were performed on the Illumina HiSeq4000 platform, processed with the Illumina pipeline, and analyzed with a Tophat-htseqDeseq2 pipeline on the GALAXY open, Internet-based platform. +/À littermates that exhibited 100% survival (Fig. 1A) . The observed improvement in survival correlated with a reduction in spontaneous seizure frequency. Video monitoring of spontaneous seizures during the period of highest seizure frequency (P23-P24) revealed a significant reduction in spontaneous seizure frequency in 1A +/À ;1G +/À mice relative to 1A +/À littermates (Fig. 1B) . Video-EEG analysis confirmed that reduction in behavioral seizures observed in mice with reduced Cacna1g expression correlated with a reduction in electrographic seizures. Furthermore, electrographic seizures that were observed in a single male 1A +/À ;1G +/À mouse had behavioral correlates indistinguishable from seizures in 1A +/À mice. The remaining 1A +/À ;1G +/À mice, as well as single mutant 1G +/À mice, had no evidence of electrographic seizures.
Results
To determine whether altered expression of
We recently reported that inducing a single, brief hyperthermia-priming GTCS in P18 F1.1A +/À mice results in a robust increase in the incidence of subsequent spontaneous GTCSs for at least 3 days. 12 To determine whether reduced Cacna1g expression influences spontaneous seizures following hyperthermia-priming, mice were monitored by continuous video recording for 60 h. The temperature threshold for the hyperthermia-priming seizure was similar among 1A
+/À and 1A +/À ;1G +/À mice (mean seizure threshold of 42.05 AE 0.33°C for 1A +/À mice and 42 AE 0.32°C for +/À mice; n = 22 per group for both groups; p Logrank = 0.689). Surprisingly, there was no significant difference in spontaneous GTCS frequency between 1A +/À and 1A +/À ;1G +/À mice following hyperthermia priming (Fig. 1C) . To examine the paradoxical effects of reduced Cacna1g expression on spontaneous GTCS frequency in naive versus hyperthermia-primed mice, we assessed whether Cacna1g expression was altered by seizure activity in the Scn1a +/À Dravet model. At P18, mice were subjected to a single, brief hyperthermia-priming GTCS or sham treatment. Whole brain RNA was collected 24 h post-treatment. We observed increased Cacna1g mRNA levels after a hyperthermiapriming seizure relative to mice in the sham treatment group (Fig. 2A) . In an independent set of 1A +/À mice, hippocampi were collected at P24 following video monitoring of spontaneous seizure frequency without prior hyperthermia-priming. Cacna1g mRNA levels were elevated in samples from mice exhibiting spontaneous GTCSs in the preceding 24 h relative to seizure-free littermates ( 
Discussion
We previously demonstrated that Cacna1g acts as a modifier of epilepsy in the Scn2a Q54 model of focal epilepsy. 7 Additionally, another modifier gene, Hlf, was found to affect both the Scn1a +/À and Scn2a Q54 epilepsy models. 9 Although both are caused by mutation or deletion of a major central nervous system voltage-gated sodium channel, the epilepsy phenotypes and underlying mechanisms of these two models are quite distinct. The Scn2a Q54 model is characterized by a progressive phenotype that begins with frequent focal motor seizures and then progresses to include GTCSs and premature death. 14 The Scn1a +/À model recapitulates hallmark Dravet phenotypes and exhibits spontaneous GTCSs, reduced lifespan, and susceptibility to hyperthermia-induced seizures, thought to be a correlate of thermally provoked seizures in Dravet syndrome. [2] [3] [4] Interestingly, the phenotypes of both the Scn1a +/À and Scn2a
Q54
epilepsy models are highly strain-dependent. 2, 4, 15 Our observations that at least two independently identified modifier genes (Hlf and Cacna1g) influence the phenotypes in both the Scn1a +/À and Scn2a Q54 models suggest that common modifier pathways are able to modify epilepsies with distinct epileptogenic mechanisms.
Although ethosuximide, a T-type calcium channel inhibitor, is utilized for the management of atypical absence seizures in Dravet syndrome, the potential for therapeutic benefit for other seizure types is unclear. Future preclinical evaluation of T-type calcium channel blockers like ethosuximide in Scn1a +/À mice will help determine the utility of pharmacologic blockade of these channels for the treatment of Dravet syndrome. +/À mice 24 h after either a priming event (hyperthermiainduced generalized tonic-clonic seizure) or a sham treatment. The expression of Cacna1g was normalized to Tbp expression. The probability value was determined by unpaired Student t test with Welch correction. Error bars represent upper and lower limits derived from standard error of the mean. Mean Cacna1g expression was observed to be the following: sham = 3.13 AU (n = 8) and primed = 3.56 AU (n = 8); *p < 0.05. (B) Differences in hippocampal Cacna1g expression between 1A +/À mice with and without observed seizure activity prior to sample collection. RNA-seq normalized count values are shown. *False discovery rate-adjusted p = 2.57e À28 (Benjamini-Hockberg procedure). AU, arbitrary units. Epilepsia ILAE
